Quixin

Quixin is a brand name of levofloxacin ophthalmic, approved by the FDA in the following formulation(s):

QUIXIN (levofloxacin - solution/drops; ophthalmic)

• 
  Manufacturer: SANTEN
  
  Approval date: August 18, 2000
  
  Strength(s): 0.5% ^[RLD][AT]

Has a generic version of Quixin been approved?

Yes. The following products are equivalent to Quixin:

levofloxacin solution/drops; ophthalmic

• 
  Manufacturer: AKORN
  
  Approval date: December 20, 2010
  
  Strength(s): 0.5% ^[AT]


• 
  Manufacturer: APOTEX
  
  Approval date: December 20, 2010
  
  Strength(s): 0.5% ^[AT]


• 
  Manufacturer: HI TECH PHARMA
  
  Approval date: February 10, 2011
  
  Strength(s): 0.5% ^[AT]


• 
  Manufacturer: NEXUS PHARMS
  
  Approval date: December 20, 2010
  
  Strength(s): 0.5% ^[AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Quixin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Quixin.

See also...

• Quixin Eye Drops Consumer Information (Wolters Kluwer)
• Quixin Consumer Information (Cerner Multum)
• Quixin Advanced Consumer Information (Micromedex)
• Quixin eent AHFS DI Monographs (ASHP)
• Levofloxacin Drops Consumer Information (Wolters Kluwer)
• Levofloxacin Eye Drops Consumer Information (Wolters Kluwer)
• Levofloxacin ophthalmic Consumer Information (Cerner Multum)
• Levofloxacin Ophthalmic Advanced Consumer Information (Micromedex)
• Levofloxacin eent AHFS DI Monographs (ASHP)